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ABSTRACT 
 
Because asbestos diseases represent a complex pattern of legal, social and political issue, 
the involvement of the mineralogist and pathologist for a multidisciplinary assess of its 
diagnosis helps to investigate the relationship between mesothelioma or lung cancer and 
occupational or environmental asbestos exposure. 
In the present study we consider the concentrations of asbestos bodies (ABs) detected by 
Optical Microscopy (OM) and Scanning Electron Microscopy (SEM), and the burden of 
different kinds of mineral fibres (among which asbestos) identified by SEM combined with 
an Energy Dispersive Spectrometer (EDS), in 10 lung tissue samples of subjects with 
occupational and non-occupational exposure to asbestos. 
In all subjects with occupational exposure to asbestos more than 1,000 ABs per gdw (gram 
of dry weight) were detected both with OM and SEM: this concentration is internationally 
accepted as suggesting high probability of past occupational exposure to asbestos. 
In nine lung samples of the ten investigated by EDS-SEM, different inorganic fibres were 
found. Asbestos fibres have been identified too, and more than 100,000 ff per gdw were 
detected in subjects with occupational exposure: this concentration is internationally 
accepted as suggesting high probability of past occupational exposure to asbestos. 
Instead, when the ABs burden is low or moderate (such as in subjects with absent or probable 
asbestos exposure), the correlation between ABs concentration determined by MO and those 
determined by SEM is lost. Therefore, when the ABs value in OM is borderline the SEM 
investigation became essential. Furthermorethe mineralogical analysis by SEM-EDS 
(identification and quantification of inorganic fibres in general, and asbestos in particular) of the 
fibres detected in the lung tissues is very useful, if not necessary, to complete the pathological 
diagnosis of asbestos-related malignancies in medico-legal field. 
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Introduction 
Asbestos has been known ad used since prehistoric times. The Ancient Greeks named it 
"unquenchable, inextinguishable". The Roman naturalist Pliny the Elder wrote about its 
harmful biological effects: they observed the “sickness of the lungs” in the slaves who worked 
with asbestos. Asbestos use did not become popular until the Industrial Revolution during the 
late 1800s. It then began to be used as insulation for steam pipes, turbines, boilers, and other 
high-temperature products. World War II provided a tremendous boost in the demand for 
asbestos and multiplied its uses. Starting from 1970 the 70% of world has output goes into 
asbestos-cement. Ancient observations of the health risks of asbestos were either forgotten 
or ignored. Only from 1920, asbestos-related disease was associated with some 
occupations, and it was during this time that reports of asbestosis began to appear in the 
literature. In 1924, was made the first diagnosis of asbestosis in the U.K. when Cooke [1] 
reported the case of a woman asbestos worker and in his paper mentioned the presence of 
mineral particles of various shapes in the lungs. Subsequently the cause of death was called 
"asbestosis" (Cooke, 1927) [2]. Nevertheless, not until 1929 did he describe the “curious 
bodies” later called “asbestos bodies” (ABs) (Cooke, 1929) [3]. The pathologist Gloyne 
(1933) [4] was the first to describe the pleural malignancy in a subject occupationally 
exposed to asbestos. Reports by Wedler (1943) [5] and Mallory (1947) [6] describing further 
cases of pleural malignancy associated with asbestos exposure followed subsequently. By 
the 1950s, malignant mesothelioma became accepted as a distinct clinicopathologic entity. 
Any remaining doubt concerning the association between pleural mesothelioma and 
asbestos occupational exposure was removed with the study described by Wagner (1960) [7] 
on cases of mesothelioma occurring in South Africa in subjects with a documented exposure 
to crocidolite. 
Although asbestos is banned in Italy (L.n°257/1992) [8], as in many other countries, its health 
consequences are still expected for at least two decades. 
Mineral fibers and ABs in lung tissue can be also present in the general population and not 
only in subjects with specific occupational exposure; actually the dose-response relationship 
has no established threshold. 
Because asbestos diseases due to occupational or environmental asbestos exposure 
represent a complex pattern of legal, social and political issue, a multidisciplinary assess of 
its diagnosis is a valid approach in legal discussions. 
When an asbestos disease is identified, it is important both to research the type of asbestos 
exposure (occupational or paraoccupational, anthropogenic or natural environmental) and to 
  
found all informations about job history and other possible asbestos exposure. The presence 
of some morphological asbestos markers of exposure (i.e. mesothelioma, pleural plaques, 
asbestosis, and asbestos bodies) helps in the study of a causal relationship between their 
presence and health impairment or death. The clinical and radiological data are useful in 
demonstrating that an asbestos disease is present, but there is nothing more persuasive than 
visual evidence that asbestos is in the lung tissue in elevated concentrations. So, one of the 
best way to demonstrate that a subject has developed an asbestos-related disease is to 
obtain a lung tissue specimen to analyze, and highlight the presence of ABs or asbestos 
fibers.  
ABs are the histological hallmark of exposure to asbestos (DeVuyst et al., 1998) [9]. They 
develop when asbestos fibers are inhaled and deposited in the lung parenchyma and have 
a characteristic microscopic appearance that is readily recognized by the pathologist. But 
also a large number of other different types of fibrous dusts (e.g. sheet silicates, carbon 
fibers, fibrous aluminium silicate, cosmetic talc, fibrous glass, etc.) can be covered (Churg 
and Warnock 1981) [10], therefore the term “ferruginous bodies” (FBs) is generally used 
when the nature of the fibrous core was not known (fibrous dusts other than asbestos can 
become coated with iron such as sheet silicates, carbon fibers, metal oxides, man-made 
mineral fibers, diatomaceous, zeolite) (Churg, 1983) [11]. 
ABs identification in histological sections are i) very low expensive methods; ii) are possible 
to do in any laboratory with a gold standard for the identification of asbestos exposure; iii) are 
important component of the pathologic diagnosis of asbestosis and their presence serves to 
alert the pathologist that the patient has been presumably exposed to airborne asbestos 
fibers (Roggli et al 2010) [12]. 
Three main methods to assess the presence of ABs and asbestos fibers in lung tissue for 
their subsequent quantification are used. These employ chemical digestion of the tissue with 
the use of either potassium hydroxide or sodium hypochlorite, and plasma ashing techniques. 
The potassium hydroxide digestion is the better method to fixed tissue, while sodium 
hypochlorite produces the best results with fresh lung specimens (Davis, 1984) [13]. Instead 
the ashing method destroying the organic component of the lung tissue but it has been 
suggested that can breakup long fibers so their amount tend to be higher than those where 
chemical digestion has been used. 
The digested samples observed under optical microscopy (OM) is a simple and inexpensive 
technique, and is more readily available than electron microscopy (EM). ABs amount is 
usually at last an order of magnitude lower than the corresponding counts made by EM 
  
(Pooley and Clark, 1980) [14]. Furthermore, OM technique cannot distinguish throw ABs from 
pseudo ABs and asbestos fibers from other inorganic fibers (because does not permit to 
identify the nature of the fiber in the core), and cannot resolve fibers less than 0.20 µm in 
diameter; therefore, several fibers are too fine to be detected by this technique. Scanning and 
Transmission Electron Microscopy (SEM and TEM) have a greater resolution, magnification 
and can be combined with an Energy Dispersive Spectrometer (EDS) therefore allow 
measurement of fibers size, and the chemical composition of the fibers burden can be 
determined too. 
The distinction between asbestos fibers and many other fibers present in human lung tissue 
is essential in establishing a diagnosis in order to correlate the tissue asbestos burden with 
various asbestos-related diseases. Their identification and quantification is pivotal to 
complete the pathological diagnoses.  
TEM-EDS is the more suitable procedure to identify fibers type and value their size but this 
method is very time-consuming and requires skilled operators. In addition the amount of 
material studied for each field of observation is very small and the particle quantification is 
almost impossible. Instead SEM-EDS is the best method for routine analyses in term of 
cost/benefit ratio. Because analytical methods to identify and quantify asbestos fibers are 
regulated by laws only for airborne and bulk samples (PCM, XRPD, FTIR, SEM-EDS), to 
detect inorganic fibers in samples of biological tissue by SEM-EDS we used the protocol 
proposed by Belluso et al. (2006) [15]. 
A multidisciplinary approach helps to investigate the relationship between the occurrence of 
mesothelioma or lung cancer and occupational or environmental asbestos exposure at the 
individual level, to resolving a critical medico-legal question. 
The present study aims to evaluate the efficiency of a pathological and mineralogical 
approach in the identification of asbestos exposure in some medico-legal cases of 
mesothelioma and lung cancer. 
 
 
Material and methods  
Through a retrospective studies we selected 10 cases of pleura-pulmonary neoplesia 
(mesothelioma and lung cancer) of which have been request anatomo-pathological 
consulting to an expert pathologist in asbestos associated diseases (dott.ssa Bellis) and 
there were an adequate quantity of material for mineralogical analyses and complete clinical 
date. 
  
The histological diagnosis of mesothelioma and lung cancer have been confirmed by 
immunohistochemistry, following international guidelines (Pinto et al., 2013) [16]. 
An accurate anamnesis to define a possible asbestos exposure (occupational or 
environmental) has been assess for each subject according to the questionnaire by the 
National Mesothelioma Registry (ReNaM, quarto rapporto, 2012) [17]. The study of the 
patient’s history includes all the information about the occupational activity, family history, 
and life style (i.e. smoke).  
The successive step has been to prepare the lung tissue samples for OM and SEM-EDS 
investigation to quantify the presence of ABs and, by SEM-EDS to quantify and identify the 
asbestos fiber in according to Belluso et al. (2006) [15]. Two portion of lung tissue from each 
subject (respectively of 0.5 g and 0.25 g) were digested in NaClO in order to eliminate the 
organic matrix and to produce a suspension of inorganic material. Both portions were filtered 
through a mixed cellulose esters membranes with a diameter of 25 mm and respectively pore 
size of 3 μm for LM examination and pore size of 0.45 μm for SEM-EDS observation. A 
portion of 2,5 g of lung tissue for each subject was dehydrated, to obtain the dry weight 
useful to determine the concentration of the Abs and fibers per gram of dry weight (gdw). 
ABs counting by OM was carried out observing the whole membrane at 400 magnification. 
Identification and quantification of inorganic fibers were carried out by SEM (Cambridge 
Stereoscan S-360) with EDS (Oxford INCA Energy 200, EDS-SDD) at 2000 magnification 
observing only a portion of filter (corresponding about 2 mm2). All the inorganic particles 
corresponding to fiber definition (greater than 5 µm in length and less than 3 µm in diameter, 
with an aspect ratio length/diameter ≥ of 3:1), were considered (Directive 2003/18/EC; WHO, 
1986) [18,19]. A chemical analysis was conducted after the observations were completed. 
The ABs and asbestos fibers amounts was normalized to 1 gdw, according to the 
international standard (De Vuyst et al., 1998) [20]. 
 
 
 
Results 
The lung samples of the 10 cases selected were investigated: seven subjects with 
mesothelioma and three subjects with lung cancer, with different kinds of asbestos exposure. 
The results about ABs and asbestos fibers detected by both OM and SEM-EDS observation 
are reported respectively in table 1 and table 2. 
 
  
About ABs 
ABs were detected by OM and SEM (figure 1), respectively in 90% and 80% of the selected 
cases. SEM detected none ABs in the lung samples of two subjects with mesothelioma: one 
with probable occupational asbestos exposure and the other without asbestos exposure 
(table 1). OM detected none ABs in the lung sample of the subject with lung cancer without 
asbestos exposure (table 2).  
In the two cases where ABs were observed by OM but not by SEM we can hypothesize: i) the 
ABs observed by OM are not really ABs but they are FBs; ii) when the ABs burden is lower 
than 1000 ABs/gdw it is possible that they are not detected by SEM because of the minor 
percentage of material prepared and observed. 
More than 1,000 ABs per gdw, value considered as indicative of high probability of 
occupational exposure to asbestos [9,21] were detected by OM e SEM respectively in 50% e 
80% of the selected case. 
In the lung samples of all subjects that have had occupational exposure to asbestos (two 
cases of mesothelioma and two cases of lung cancer), more than 1,000 ABs per gdw were 
detected by both OM and SEM observation, as expected. ABs were also detected by OM 
observation in the lung samples of all subjects that have had probable occupational exposure 
to asbestos (three cases of mesothelioma); in two of these cases ABs were detected by SEM 
investigation too. However only in one case more than 1,000 ABs per gdw were counted both 
by OM (2,500 ABs/gdw) and SEM (6,120 ABs/gdw). In the other two cases this value result 
respectively slightly below (832 ABs/gdw) and very low (143 ABs/gdw) when the observation 
was carried out by OM; ABs concentration is over the limit (3,825 ABs/gdw) and not present 
(0 ABs/gdw) when the investigation was carried out by SEM. 
In the only case of probable environmental exposure to asbestos (case of mesothelioma) 
ABs amount is lower than the limit (415 ABs/gdw) when the investigation was carried out by 
OM, and over (33,444 ABs/gdw) when the investigation was carried out by SEM. 
The lung samples investigation of the two subjects without asbestos exposure (one case of 
mesothelioma and one case of lung cancer) has shown that the ABs amount is respectively 
lower of the limit (800 ABs/gdw) and absent (0 ABs/gdw) when the observation was carried 
out by OM, as expected; while, when the investigation was carried out by SEM-EDS, ABs are 
also absent (0 ABs/gdw) in the subject with mesothelioma but over the limit (4,936 ABs/gdw) 
in the subject with lung cancer. 
Some studies point out the correlation between ABs count by OM and by SEM (in subjects 
with occupational exposure) [21,22]. We have to consider that when the ABs burden is low or 
  
moderate (such as in subjects with absent or probable asbestos exposure) the correlation 
between ABs concentration determined by MO and those determined by SEM is lost. 
Therefore, when the ABs value in OM is borderline the SEM investigation became essential. 
 
About uncoated fibers 
In nine lung samples of the ten investigated, different inorganic fibrous uncoated species has 
been determined by EDS-SEM (figures 2,3). Among these, six were identified as asbestos. 
Five of them are amphiboles: asbestos tremolite, asbestos actinolite, asbestos grunerite, 
asbestos anthophyllite, and crocidolite. As it concerns tremolite and actinolite asbestos, they 
are grouped together because their chemical characterization cannot be determined by 
qualitative EDS-SEM analyses.  
Due to the difficulty in distinguishing chrysotile (asbestos) and antigorite (non asbestos) using 
this technique we considered them as a sole group, named chrysotile-antigorite group. 
Between the subjects with occupational exposure, in two cases (one of mesothelioma and 
one of lung cancer) fibers could not be chemically identified because their diameter was too 
thin. In the other case of lung cancer 45,900 ff/gdw asbestos grunerite (57%), 27,540 
crocidolite (34%) and 6,120 ff/gdw chrysotile-antgorite (7.7%) were detected. Crocidolite 
(79.940 ff/gdw) was the only fiber chemically identified in the last case while 70% of the fibers 
was too thin. The concentration of asbestos fibers in these two cases are about 80.000 
ff/gdw, a value slightly below the limit of 100,000 ff/gdw (quantities internationally established 
as indicative of significant amphibole asbestos exposure). 
 
 
Discussion 
Unfortunately, legal aspect is not considered in the first step of diagnosis of malignant 
mesothelioma or lung cancer. Only after the death of the patient can turned out evident the 
necessary of retrospective studies. Nevertheless, sometime the material (i.e. lung tissue) for 
a thorough investigation is not available because an autopsy was not been request.  
The new technologies in the field of pathology (e.g. molecular therapies, endoscopy, and 
molecular radiology) could not forget the conventional investigation by OM and by SEM-EDS 
in the diagnosis of occupational asbestos diseases (i.e. mesothelioma). 
Mesothelioma and lung cancer (by asbestos exposure) diagnosis can be made with cytology, 
histology of biopsy, histological examination of the surgical specimen, or histological 
examination of autopsy material (pathologists’ involvement). In 1981, Mark [23] was thw first 
  
to suggest the “second diagnosis” as another important aspect of the pathologist’s role: the 
identification of other abnomalies related to asbestos fibers inhalation. 
The aim of our study is to underline that the demonstration of the presence of asbestos 
(mineralogical identification by SEM-EDS investigation) and its burden in lung tissue of 
subjects with possible asbestos neoplastic diseases (mineralogists’ involvement) represent 
an important medico-legal value because confirm a past exposure. 
In fact, it is not possible to attest that the mesothelioma or lung cancer are due to asbestos 
exposure only known the work activity or other possible exposure (e.g. environmental) of the 
subject. Therefore, it is important to be able to attest the relation between asbestos fibers or 
other kind of fibers exposure and the pathology of the patient for a prevention question. For 
this reason, when the patient dies, a correct diagnosis must be done on autopsy material, 
especially in the case of suspected occupational disease. 
The chemical analysis by EDS-SEM of the fibers detected in lung samples of subjects with 
pulmonary ills can be correlated with the life background (occupational and/or 
environmental). 
The histopathological diagnosis of mesothelioma and lung cancer, and the mineralogical 
investigation of fibers inhaled, require a multidisciplinary group of study. The results obtained 
represent an important service to the society (e.g. reducing number and costs of litigation 
process). 
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Figure legend 
Fig 1. Backscattered electron SEM image of twin ABs (2000X) 
Fig 2. Backscattered electron SEM image (2000X) of crocidolite 
Fig 3. EDS/SEM spectrum of crocidolite 
Figure 1
Figure 2
Figure 3
  
 
MESOTHELIOMA 
cases 
asbestos 
exposure 
OM 
ABs/gdw 
SEM 
AB/gdw 
SEM-EDS asbestos 
ff/gdw 
1 occupational >1,000 363,375 
fibers too thin  
to investigate  
by SEM-EDS 
2 occupational 42,840 228,400 
70% fibers too thin to investigate  
by SEM-EDS 
79,940: crocidolite 
3 
occupational 
probable 
2,500 6,120 18,000 tremolite-actinolite asbestos 
4 
occupational 
probable 
832 3,825 
111,807 anthophyllite asbestos 
695 tremolite-actinolite asbestos 
695 crocidolite 
5 
occupational 
probable 
143 0 
4,370 anthophyllite asbestos 
8,743 tremolite asbestos 
17,486 crocidolite 
6 absent 800 0 6,120 tremolite-actinolite asbestos 
7 
environment
al probable 
415 33,444 
16,722 tremolite-actinolite asbestos 
33,444 chrysotile-antigorite 
16,722 crocidolite 
 
 
Tab 1. ABs detected by both OM and SEM observation, and asbestos fibres  
investigated by EDS-SEM in lung samples of subjects with mesothelioma. 
 
ABs, Asbestos Bodies 
gdw, gram of dry weight 
OM, Optical Microscopy 
SEM, Scanning Electron Microscopy 
EDS-SEM, Energy Dispersive Spectrometer 
 
 
Table 1
  
 
LUNG CANCER 
cases 
asbestos 
exposure 
OM 
ABs/gdw 
SEM 
AB/gdw 
SEM-EDS asbestos 
ff/gdw 
1 occupational >1,000 342,720 
45,900 grunerite asbestos 
6,120 crysotile-antigorite 
27,540 crocidolite 
2 occupational 48,000 11,946,240 
fibers too thin  
to investigate  
by SEM-EDS 
 
3 
 
absent 0 4,935 0 
 
Tab 2. ABs detected by both OM and SEM observation and, asbestos fibres 
investigated by EDS-SEM in lung samples of subjects with lung cancer 
 
ABs, Asbestos Bodies 
gdw, gram of dry weight 
OM, Optical Microscopy 
SEM, Scanning Electron Microscopy 
EDS-SEM, Energy Dispersive Spectrometer 
 
Table 2
